0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Mohamad E. Allaf, MD; Alan W. Partin, MD
JAMA Surg. 2014;149(8):852. doi:10.1001/jamasurg.2014.41.

Original Investigation |  FREE
J. Kellogg Parsons, MD, MHS; Karen Messer, PhD; Kerrin Palazzi, MPH; et al.
JAMA Surg. 2014;149(8):845-851. doi:10.1001/jamasurg.2014.31.

JAMA Surgery Clinical Challenge | 
Areg Grigorian, BS; Ann M. Ponsford Tipps, MD; Ithaar H. Derweesh, MD; et al.
JAMA Surg. 2014;149(7):741-742. doi:10.1001/jamasurg.2013.3948.

Special Feature |  FREE
Arch Surg. 2011;146(2):238. doi:10.1001/archsurg.2010.339-b.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States A Nationwide Survey Analysis
Firas Abdollah, MD; Maxine Sun, MPH; Jesse D. Sammon, DO; et al.
JAMA Oncology
Original Investigation  | 
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both The TRAPEZE Randomized Clinical Trial
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncology
Invited Commentary  | 
DNA Damage and Repair Pathway Profiles as Biomarkers in High-Risk Prostate Cancer
Sean E. McGuire, MD, PhD
JAMA Oncology
Invited Commentary  | 
Targeted Cancer Screening After Solid-Organ Transplantation
Marianne Schmid, MD; Felix K.-H. Chun, MD; Quoc-Dien Trinh, MD